Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes.
Authors: Coorey CP; Cardiology Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Tang O; Cardiology Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Li M; Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia., Kim T; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia., Vescovi J; Cardiology Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Vernon ST; Cardiology Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Neal B; The George Institute for Global Health, Sydney, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Arnott C; The George Institute for Global Health, Sydney, New South Wales, Australia.; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Ferrannini E; CNR (National Research Council) Institute of Clinical Physiology, Pisa, Italy., Burrell LM; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia., Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Grieve SM; Imaging and Phenotyping Laboratory, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Radiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Yang JYH; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia., O'Sullivan JF; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Heart Failure and Diseases of the Aorta, The Baird Institute, Sydney, New South Wales, Australia., Figtree GA; Cardiology Discovery Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia gemma.figtree@sydney.edu.au.; Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Source: Heart (British Cardiac Society) [Heart] 2026 Jun 05. Date of Electronic Publication: 2026 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-201X
DOI:10.1136/heartjnl-2025-327466